Compass Therapeutics
CMPX | NASDAQ
$0.66
-$0.11 (-14.71%)
At close: Nov 16, 2026, 4:00 PM ET
$0.70
+$0.04 (+6.38%)
After-hours:
Nov 16, 2026, 7:27 PM ET
-14.71%
(1D)No price chart data available for 1D timeframe.
Rating
17.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1007/1021 (Top 99%)
Key Statistics
Market Data
Market Cap $119.13M
1D Range
0.66 0.78
52W Range
0.66 6.69
Valuation (TTM)
PE -1.43
PB 0.84
EV/EBITDA 0.41
Valuation (NTM)
Forward PE N/A
Forward PEG -0.08
Price Target $4.00
Cash Flow
FCF Yield -50.9%
SBC Adj. FCF Yield -64.1%
SBC Impact -25.9%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
0.0%
Dil EPS 3Y | 5Y -11.6% |
-1.2%
FCF 3Y | 5Y -12.2% |
-15.5%
Returns
ROA -49.5%
ROE -49.9%
ROIC -62.0%
Financial Health
Net Cash
$163.06M
Current Ratio 6.79
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating a...
Sector Healthcare
Industry Biotechnology
Employees 39
IPO Date Apr 5, 2021
Website www.compasstherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
8
Consensus
Buy
Price Target
$4.00
Upside
+506.06%
Buy (7)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CMPX